Immunomodulatory effects of antimicrobial agents. Part II: antiparasitic and antifungal agents

Immunomodulatory effects of antimicrobial agents. Part I: antibacterial and antiviral agents

(2012) Marie-Thérèse Labro   Expert Review of Anti-Infective Therapy

Artemisinins and immune system

(2011) Lubna Shakir et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Severe hypersensitivity reaction as acute eosinophilic pneumonia and skin eruption induced by proguanil

(2011) N. Just et al.   EUROPEAN RESPIRATORY JOURNAL

Drugs for Neglected Diseasesinitiativemodel of drug development for neglected diseases: current status and future challenges

(2011) Jean-Robert Ioset et al.   Future Medicinal Chemistry

Immunomodulation by chemotherapeutic agents against Leishmaniasis

(2011) Piu Saha et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Miltefosine Effectively Modulates the Cytokine Milieu in Indian Post Kala-Azar Dermal Leishmaniasis

(2011) Debanjan Mukhopadhyay et al.   JOURNAL OF INFECTIOUS DISEASES

Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial

(2011) Nicholas I Paton et al.   LANCET INFECTIOUS DISEASES

Antiparasitic Therapy

(2011) Shanthi Kappagoda et al.   MAYO CLINIC PROCEEDINGS

First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

A Research Agenda for Malaria Eradication: Vaccines

(2011)   PLOS MEDICINE

Review article: the role of non-biological drugs in refractory inflammatory bowel disease

(2010) S. C. Ng et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Tolerance of Benznidazole in Treatment of Chagas' Disease in Adults

(2010) M.-J. Pinazo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Role of the NF-κB transcription pathway in the haemozoin- and 15-HETE-mediated activation of matrix metalloproteinase-9 in human adherent monocytes

(2010) Mauro Prato et al.   CELLULAR MICROBIOLOGY

Tolerance and Safety of Nifurtimox in Patients with Chronic Chagas Disease

(2010) Yves Jackson et al.   CLINICAL INFECTIOUS DISEASES

Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: A retrospective, observational, sequential cohort analysis

(2010) David W. Kubiak et al.   CLINICAL THERAPEUTICS

Ciclopirox

(2010) Alessandro Subissi et al.   DRUGS

Mycoviruses: future therapeutic agents of invasive fungal infections in humans?

(2010) W. W. J. Sande et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

DNA vaccines: a rational design against parasitic diseases

(2010) Joana A Carvalho et al.   Expert Review of Vaccines

The antitumor activity of the fungicide ciclopirox

(2010) Hongyu Zhou et al.   INTERNATIONAL JOURNAL OF CANCER

The repositioning of the anti-fungal agent ciclopirox olamine as a novel therapeutic agent for the treatment of haematologic malignancy

(2010) S. J. Weir et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

In vivo efficacy of griseofulvin against multiple myeloma

(2010) Young Kim et al.   LEUKEMIA RESEARCH

Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus

(2010) A. Lesiak et al.   LUPUS

Immunomodulatory effects of antifungal agents on the response of human monocytic cells toAspergillus fumigatusconidia

(2010) Jung-Hyun Choi et al.   MEDICAL MYCOLOGY

The development of drugs for treatment of sleeping sickness: a historical review

(2010) Dietmar Steverding   Parasites & Vectors

Adverse Events After the Use of Benznidazole in Infants and Children With Chagas Disease

(2010) J. Altcheh et al.   PEDIATRICS

Paromomycin for the Treatment of Visceral Leishmaniasis in Sudan: A Randomized, Open-Label, Dose-Finding Study

(2010) Ahmed M. Musa et al.   PLoS Neglected Tropical Diseases

Geographical Variation in the Response of Visceral Leishmaniasis to Paromomycin in East Africa: A Multicentre, Open-Label, Randomized Trial

(2010) Asrat Hailu et al.   PLoS Neglected Tropical Diseases

Identification of Attractive Drug Targets in Neglected-Disease Pathogens Using an In Silico Approach

(2010) Gregory J. Crowther et al.   PLoS Neglected Tropical Diseases

Miltefosine Efficiently Eliminates Leishmania major Amastigotes from Infected Murine Dendritic Cells without Altering Their Immune Functions

(2009) K. Griewank et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antiviral Activity of Chloroquine against Human Coronavirus OC43 Infection in Newborn Mice

(2009) E. Keyaerts et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Immunotherapy as a strategy for treatment of leishmaniasis: a review of the literature

(2009) Ifeoma Okwor et al.   Immunotherapy

SM934, a water-soluble derivative of arteminisin, exerts immunosuppressive functions in vitro and in vivo

(2009) Li-Fei Hou et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Dihydroartemisinin can inhibit calmodulin, calmodulin-dependent phosphodiesterase activity and stimulate cellular immune responses

(2009) Shokoofe Noori et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

The early years of Toxoplasma research: What’s past is prologue

(2009) Naomi S. Morrissette et al.   INTERNATIONAL JOURNAL FOR PARASITOLOGY

Miltefosine Promotes IFN- -Dominated Anti-Leishmanial Immune Response

(2009) P. Wadhone et al.   JOURNAL OF IMMUNOLOGY

Inhibition of HIV-1 gene expression by Ciclopirox and Deferiprone, drugs that prevent hypusination of eukaryotic initiation factor 5A

(2009) Mainul Hoque et al.   Retrovirology

Immunological stimulation for the treatment of leishmaniasis: a modality worthy of serious consideration

(2009) Ahmed Mudawi Musa et al.   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE

Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review

(2008) G Ruiz-Irastorza et al.   ANNALS OF THE RHEUMATIC DISEASES

Immunomodulatory Effects of Voriconazole on Monocytes Challenged with Aspergillus fumigatus: Differential Role of Toll-Like Receptors

(2008) M. Simitsopoulou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Progress in research on the anti-tumor effect of artesunate

(2008) Rong-rong He et al.   Chinese Journal of Integrative Medicine

High Risk of Neutropenia in HIV‐Infected Children following Treatment with Artesunate plus Amodiaquine for Uncomplicated Malaria in Uganda

(2008) Anne F. Gasasira et al.   CLINICAL INFECTIOUS DISEASES

Immunocompromised Hosts: Immunopharmacology of Modern Antifungals

(2008) R. Ben‐Ami et al.   CLINICAL INFECTIOUS DISEASES

Current Status of Vaccines for Schistosomiasis

(2008) D. P. McManus et al.   CLINICAL MICROBIOLOGY REVIEWS

A Possible Mechanism for Synergy between Antifungal Therapy and Immune Defenses

(2008) David A. Stevens   JOURNAL OF INFECTIOUS DISEASES

Caspofungin‐Mediated β‐Glucan Unmasking and Enhancement of Human Polymorphonuclear Neutrophil Activity againstAspergillusand Non‐AspergillusHyphae

(2008) Gregory A. Lamaris et al.   JOURNAL OF INFECTIOUS DISEASES

Defining targets for investigating the pharmacogenomics of adverse drug reactions to antifungal agents

(2008) Joseph Meletiadis et al.   PHARMACOGENOMICS

Antifungal Immunotherapy and Immunomodulation: A Double-hitter Approach to Deal with Invasive Fungal Infections

(2008) M. Hamad   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Immune response following miltefosine therapy in a patient with post-kala-azar dermal leishmaniasis

(2008) Nasim Akhtar Ansari et al.   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE

Paromomycin

(2008) Robert N. Davidson et al.   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE

DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo

(2008) Akram A. Da’Dara et al.   VACCINE

Anti-Inflammatory Activity of Sertaconazole Nitrate Is Mediated via Activation of a p38–COX-2–PGE2 Pathway

(2007) Runa Sur et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Ciclopirox protects mitochondria from hydrogen peroxide toxicity

(2005) Sun J Lee et al.   BRITISH JOURNAL OF PHARMACOLOGY